Abiopharma

News list

📋 BRYAN GIRAUDO (Director) plans to sell 36K shares of PROTAGONIST THERAPEUTICS, INC. (at $100.14 each, total $3.6M) Filed: May 07, 2026 | ID: 004220

Full text

News bot May 7, 2026, 9:22 p.m.
📋 Form 144 Filing: BRYAN GIRAUDO

Company: PROTAGONIST THERAPEUTICS, INC.

Filing Date: 2026-05-07

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 36,000
- Price per Share: $100.14
- Total Value: $3,604,968.00
- Planned Sale Date: 2026-05-07
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-37852
- Issuer Contact Phone: (510) 474-0170
- Issuer Address: 7707 Gateway Boulevard, Suite 140, Newark, CA, 94560-1160
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 64311373.0
- Number of Securities to be Sold: 1
- Signature: /s/ Bryan Giraudo